155 results on '"Walder, Gernot"'
Search Results
2. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
3. Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of age on humoral and cellular TBEV-specific immune responses in patients with rheumatoid arthritis
4. Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series
5. An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value
6. Smell and Taste Disorders in COVID-19 Patients: Objective Testing and Magnetic Resonance Imaging in Five Cases
7. Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq value
8. Monitoring of alien mosquitoes of the genus Aedes (Diptera: Culicidae) in Austria
9. Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants
10. Prevalence and Seroprevalence of Non-SARS Human Coronaviruses 229E and OC43 in East Tyrol/Austria
11. Comparison of Pfizer/BioNTech BNT162b2 COVID-19 (Comirnaty) Vaccination Effects in Aged Adults with Special Consideration for the Effectiveness of the Three-Color iSpot in Assessing Immune Response
12. Borrelia burgdorferi sensu stricto and Borrelia afzelii: Population structure and differential pathogenicity
13. Roe deer sera used for TBE surveillance in Austria
14. Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees
15. The mutational steps of SARS-CoV-2 to become like Omicron within seven months: the story of immune escape in an immunocompromised patient.
16. Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients
17. Tick-borne encephalitis in the Tyrol (Austria): Changes in incidence and endemicity 2000–2006
18. Risk assessment of transfusion-associated babesiosis in Tyrol: appraisal by seroepidemiology and polymerase chain reaction
19. Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.
20. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses
21. Home quarantine in COVID-19: A study on 50 consecutive patients in Austria
22. SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes
23. Maintenance of neutralizing SARS-CoV-2 antibodies over five months in convalescent SARS-CoV-2 afflicted patients.
24. First documented case of human granulocytic ehrlichiosis in Austria
25. Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia
26. Monitoring of alien mosquitoes in Western Austria (Tyrol, Austria, 2018)
27. Anosmia and ageusia in COVID-19 patients: Objective testing and Magnetic Resonance Imaging in five cases
28. Presence of Chlamydophila psittaci DNA in the Central Nervous System of a Patient with Status Epilepticus
29. Chlamydophila abortus pelvic inflammatory disease
30. Encephalitis lethargica following Bartonella henselae infection
31. Improving the results of resuscitation through structural alterations
32. Guidelines for the Direct Detection ofAnaplasmaspp. in Diagnosis and Epidemiological Studies
33. Practical Guidelines for Studies on Sandfly-Borne Phleboviruses: Part I: Important Points to Consider Ante Field Work
34. Practical Guidelines for Studies on Sandfly-Borne Phleboviruses: Part II: Important Points to Consider for Fieldwork and Subsequent Virological Screening
35. Guidelines for the Detection ofBabesiaandTheileriaParasites
36. Analysis of Humoral Immune Responses to Surface and Virulence-Associated Chlamydiaabortus Proteins in Ovine and Human Abortions by Use of a Newly Developed Line Immunoassay
37. Guidelines for the Direct Detection of Anaplasma spp. in Diagnosis and Epidemiological Studies.
38. Investigations on California Serogroup Orthobunyaviruses in the Tyrols: First Description of Tahyna Virus in The Alps
39. Candidatus Neoehrlichia mikurensis and its co-circulation with Anaplasma phagocytophilum in Ixodes ricinus ticks across ecologically different habitats of Central Europe
40. Profiling Antibody Responses to Infections by Chlamydia abortus Enables Identification of Potential Virulence Factors and Candidates for Serodiagnosis
41. Diminished response to tick-borne encephalitis vaccination in thymectomized children
42. Co-infection with two Chlamydophila species in a case of fulminant myocarditis*
43. Human granulocytic anaplasmosis in Austria: Epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria
44. An Unusual Cause of Sepsis During Pregnancy
45. A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity
46. Chlamydophila abortusPelvic Inflammatory Disease
47. Analysis of Humoral Immune Responses to Surface and Virulence-Associated ChlamydiaabortusProteins in Ovine and Human Abortions by Use of a Newly Developed Line Immunoassay
48. Candidatus Neoehrlichia mikurensis and its cocirculation with Anaplasma phagocytophilum in Ixodes ricinus ticks across cologically different habitats of Central Europe.
49. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses
50. Immunogenicity of tick-borne-encephalitis-virus-(TBEV)-vaccination and impact of age on humoral and cellular TBEV-specific immune responses in patients with rheumatoid arthritis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.